These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 33498503)
1. Flavonoids: Potential Candidates for the Treatment of Neurodegenerative Disorders. Devi S; Kumar V; Singh SK; Dubey AK; Kim JJ Biomedicines; 2021 Jan; 9(2):. PubMed ID: 33498503 [TBL] [Abstract][Full Text] [Related]
2. Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases. Wang L; Fang X; Ling B; Wang F; Xia Y; Zhang W; Zhong T; Wang X Front Cell Neurosci; 2024; 18():1359453. PubMed ID: 38515787 [TBL] [Abstract][Full Text] [Related]
3. New opportunities for antioxidants in amelioration of neurodegenerative diseases. Bhandari UR; Danish SM; Ahmad S; Ikram M; Nadaf A; Hasan N; Kesharwani P; Ahmad FJ Mech Ageing Dev; 2024 Oct; 221():111961. PubMed ID: 38960099 [TBL] [Abstract][Full Text] [Related]
4. Revisiting the Mitochondrial Function and Communication in Neurodegenerative Diseases. Wankhede NL; Kale MB; Umare MD; Lokhande S; Upaganlawar AB; Wal P; Taksande BG; Umekar MJ; Khandige PS; Singh B; Sadananda V; Ramniwas S; Behl T Curr Pharm Des; 2024; 30(12):902-911. PubMed ID: 38482626 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of flavonoids: endoplasmic reticulum as the target. Amiri B; Yazdani Tabrizi M; Naziri M; Moradi F; Arzaghi M; Archin I; Behaein F; Bagheri Pour A; Ghannadikhosh P; Imanparvar S; Akhtari Kohneshahri A; Sanaye Abbasi A; Zerangian N; Alijanzadeh D; Ghayyem H; Azizinezhad A; Ahmadpour Youshanlui M; Poudineh M Front Neurosci; 2024; 18():1348151. PubMed ID: 38957188 [TBL] [Abstract][Full Text] [Related]
6. Preclinical Research of Dihydromyricetin for Brain Aging and Neurodegenerative Diseases. Martínez-Coria H; Mendoza-Rojas MX; Arrieta-Cruz I; López-Valdés HE Front Pharmacol; 2019; 10():1334. PubMed ID: 31780947 [TBL] [Abstract][Full Text] [Related]
7. Recent Advances in the Synthesis of Antioxidant Derivatives: Pharmacological Insights for Neurological Disorders. Singh K; Gupta JK; Sethi P; Mathew S; Bhatt A; Sharma MC; Saha S; Shamim D; Kumar S Curr Top Med Chem; 2024 Aug; ():. PubMed ID: 39108007 [TBL] [Abstract][Full Text] [Related]
8. Proteotoxicity: A Fatal Consequence of Environmental Pollutants-Induced Impairments in Protein Clearance Machinery. Devi S; Kim JJ; Singh AP; Kumar S; Dubey AK; Singh SK; Singh RS; Kumar V J Pers Med; 2021 Jan; 11(2):. PubMed ID: 33503824 [TBL] [Abstract][Full Text] [Related]
9. Mechanistic new insights of flavonols on neurodegenerative diseases. Tahir MS; Almezgagi M; Zhang Y; Bashir A; Abdullah HM; Gamah M; Wang X; Zhu Q; Shen X; Ma Q; Ali M; Solangi ZA; Malik WS; Zhang W Biomed Pharmacother; 2021 May; 137():111253. PubMed ID: 33545661 [TBL] [Abstract][Full Text] [Related]
10. Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases. Akter R; Rahman H; Behl T; Chowdhury MAR; Manirujjaman M; Bulbul IJ; Elshenaw SE; Tit DM; Bungau S CNS Neurol Disord Drug Targets; 2021; 20(5):430-450. PubMed ID: 33602109 [TBL] [Abstract][Full Text] [Related]
11. A Review on Potential Footprints of Ferulic Acid for Treatment of Neurological Disorders. Thapliyal S; Singh T; Handu S; Bisht M; Kumari P; Arya P; Srivastava P; Gandham R Neurochem Res; 2021 May; 46(5):1043-1057. PubMed ID: 33547615 [TBL] [Abstract][Full Text] [Related]
12. A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease. Lee JH; Kim HJ; Kim JU; Yook TH; Kim KH; Lee JY; Yang G Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525754 [TBL] [Abstract][Full Text] [Related]
13. Glial Cell Dysfunction in Ghasemi M; Keyhanian K; Douthwright C Cells; 2021 Jan; 10(2):. PubMed ID: 33525344 [TBL] [Abstract][Full Text] [Related]
14. Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol. Rahul ; Siddique YH CNS Neurol Disord Drug Targets; 2021; 20(4):327-342. PubMed ID: 33511932 [TBL] [Abstract][Full Text] [Related]
15. Review of Evidence and Perspectives of Flavonoids on Metabolic Syndrome and Neurodegenerative Disease. Zilli AMH; Zilli EM Protein Pept Lett; 2021; 28(7):725-734. PubMed ID: 33504293 [TBL] [Abstract][Full Text] [Related]
16. Flavonoids as Potential Therapeutics Against Neurodegenerative Disorders: Unlocking the Prospects. Faysal M; Dehbia Z; Zehravi M; Sweilam SH; Haque MA; Kumar KP; Chakole RD; Shelke SP; Sirikonda S; Nafady MH; Khan SL; Nainu F; Ahmad I; Emran TB Neurochem Res; 2024 Aug; 49(8):1926-1944. PubMed ID: 38822985 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective potential of Afzelin: A novel approach for alleviating catalepsy and modulating Bcl-2 expression in Parkinson's disease therapy. Alharthy KM; Rashid S; Yusufoglu HS; Alqasoumi SI; Ganaie MA; Alam A Saudi Pharm J; 2024 Feb; 32(2):101928. PubMed ID: 38261905 [TBL] [Abstract][Full Text] [Related]
18. Huntington's Disease: Understanding Its Novel Drugs and Treatments. Dhingra H; Gaidhane SA Cureus; 2023 Oct; 15(10):e47526. PubMed ID: 38021751 [TBL] [Abstract][Full Text] [Related]
19. Emerging Role of Plant-Based Bioactive Compounds as Therapeutics in Parkinson's Disease. Kumari N; Anand S; Shah K; Chauhan NS; Sethiya NK; Singhal M Molecules; 2023 Nov; 28(22):. PubMed ID: 38005310 [TBL] [Abstract][Full Text] [Related]